Changing outcomes and treatment strategies for wire induced coronary perforations in the era of bivalirudin use

Catheterization and Cardiovascular Interventions

Volumn 74, Issue 5, 2009, Pages 700-707

  Kini, Annapoorna S ^a   Rafael, Oana C ^a   Sarkar, Kunal ^a   Rajdev, Sanjay ^a   Jakkula, Madhavi ^a   Mares, Angelica M ^a   Kaplish, Dheeraj ^a   Krishnan, Prakash ^a   Kim, Michael C ^a   Sharma, Samin K ^a  

^a MOUNT SINAI HOSPITAL   (United States)

Author keywords

Percutaneous coronary intervention (PCI); Wire perforation (WP)

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; HIRULOG; PROTAMINE SULFATE;

AGED; ANGIOCARDIOGRAPHY; ANTICOAGULATION; ARTICLE; COIL EMBOLIZATION; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; CORONARY ARTERY PERFORATION; DISEASE CLASSIFICATION; DRUG WITHDRAWAL; EXTRAVASATION; FEMALE; GUIDE WIRE; HEART DISEASE; HEART TAMPONADE; HUMAN; HYDROPHILICITY; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PERICARDIOCENTESIS; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTICOAGULANTS; BALLOON OCCLUSION; CARDIAC TAMPONADE; CINEANGIOGRAPHY; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY VESSELS; FEMALE; HEPARIN; HEPARIN ANTAGONISTS; HIRUDINS; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PEPTIDE FRAGMENTS; PERICARDIOCENTESIS; RECOMBINANT PROTEINS; REGISTRIES; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; WOUNDS, PENETRATING;

EID: 70350591013     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.22112     Document Type: Article

References (14)

1. Ellis SG, Ajluni S, Arnold AZ, Popma JJ, Bittl JA, Eigler NL, Cowley MJ, Raymond RE, Safian RD, Whitlow PL. Increased coronary perforation in the new device era. Incidence, classification, management, and outcome. Circulation 1994;90:2725-2730.
2. Fasseas P, Orford J, Panetta C, Bell M, Denktas A, Lennon R, Holmes DR, Berger PB. Incidence, correlates, management, and clinical outcome of coronary perforation: Analysis of 16,298 procedures. Am Heart J 2004;147:140-145. (Pubitemid 38037410)
3. Fukutomi T, Suzuki T, Popma J, Hosokawa H, Yokoya K, Inada T, Hayase M, Kondo H, Ito S, Suzuki S, Itoh M. Early and late clinical outcomes following coronary perforation in patients undergoing percutaneous coronary intervention. Circ J 2002;66:349-356. (Pubitemid 34462387)
4. Lincoff AM, Bittl JA, Harrington RA, et al. Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial. JAMA 2003;289:853-863. (Pubitemid 37430344)
5. Lincoff AM, Kleiman NS, Kereiakes DJ, et al. Long-term efficacy of bivalirudin and provisional glycoprotein IIb/IIIa blockade vs heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary revascularization: REPLACE-2 randomized trial. JAMA 2004;292:696-703. (Pubitemid 39062523)
6. Stone GW, McLaurin BT, Cox DA, Bertrand ME, Lincoff AM, Moses JW, White HD, Pocock SJ, Ware JH, Feit F, Colombo A, Aylward PE, Cequier AR, Darius H, Desmet W, Ebrahimi R, Hamon M, Rasmussen LH, Rupprecht HJ, Hoekstra J, Mehran R, Ohman EM; ACUITY Investigators. Bivalirudin for patients with acute coronary syndromes. N Engl J Med 2006; 355:2203-2216. (Pubitemid 44791162)
7. Mahmud E, Douglas J. Coil embolization for successful treatment of perforation of chronically occluded proximal coronary artery. Catheter Cardiovasc Interv 2001;53:549-552. (Pubitemid 32729260)
8. Yoo BS, Yoon J, Lee SH, Kim JY, Lee HH, Ko JY, Lee BK, Hwang SO, Choe KH. Guidewire-induced coronary artery perforation treated with transcatheter injection of polyvinyl alcohol form. Catheter Cardiovasc Interv 2001;52:231-234. (Pubitemid 32115141)
9. Oda H, Oda M, Makiyama Y, Kashimura T, Takahashi K, Miida T, Higuma N. Guidewire-induced coronary artery perforation treated with transcatheter delivery of subcutaneous tissue. Catheter Cardiovasc Interv 2005;66:369-374. (Pubitemid 41572032)
10. Fischell T, Korban E, Lauer M. Successful treatment of distal coronary guidewire-induced perforation with balloon catheter delivery of intracoronary thrombin. Catheter Cardiovasc Interv 2003;58:370-374. (Pubitemid 36259229)
11. Aslam MS, Messersmith RN, Gilbert J, Lakier J. Successful management of coronary artery perforation with helical platinum microcoil embolization. Catheter Cardiovasc Interv 2000; 51:320-322. (Pubitemid 30834462)
12. Dippel EJ, Kereiakes DJ, Tramuta DA, Broderick TM, Shimshak TM, Roth EM, Hattemer CR, Runyon JP, Whang DD, Schneider JF, Abbottsmith CW. Coronary perforation during percutaneous coronary intervention in the era of abciximab platelet glycoprotein IIb/IIIa blockade: An algorithm for percutaneous management. Catheter Cardiovasc Interv 2001;52:279-286. (Pubitemid 32184868)
13. Anand SX, Kim MC, Kamran M, Sharma SK, Kini AS, Fareed J, Hoppensteadt DA, Carbon F, Cavusoglu E, Varon D, Viles- Gonzalez JF, Badimon JJ, Marmur JD. Comparison of platelet function and morphology in patients undergoing percutaneous coronary intervention receiving bivalirudin versus unfractionated heparin versus clopidogrel pretreatment and bivalirudin. Am J Cardiol 2007;100:417-424. (Pubitemid 47094690)
14. Di Mario C, Werner GS, Sianos G, Galassi AR, Buttner J, Dudek D, Chevalier B, Lefevre T, Schofer J, Koolen J, Sievert H, Reimers B, Fajadet J, Colombo A, Gershlick A, Serruys PW, Reifart N. European perspective in the recanalisation of Chronic Total Occlusions (CTO): Consensus document from the Euro-CTO Club. EuroIntervention 2007;3:30-43.